These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Mechanism of bullous formation in porphyria cutanea tarda. 1. Histopathological observation of bullae in 3 cases of porphyria cutanea tarda]. Nagato N; Ohgami T; Murayama F; Honda T; Nonaka S; Yoshida H Nihon Hifuka Gakkai Zasshi; 1987 Mar; 97(4):471-7. PubMed ID: 3613213 [No Abstract] [Full Text] [Related]
44. Naproxen-induced pseudoporphyria. A clinical and ultrastructural study. Judd LE; Henderson DW; Hill DC Arch Dermatol; 1986 Apr; 122(4):451-4. PubMed ID: 3954412 [TBL] [Abstract][Full Text] [Related]
45. Phototoxic bullous eruptions due to nalidixic acid. Birkett DA; Garretts M; Stevenson CJ Br J Dermatol; 1969 May; 81(5):342-4. PubMed ID: 5795770 [No Abstract] [Full Text] [Related]
46. Pseudoporphyria due to naproxen. Lancet; 1985 May; 1(8438):1166-7. PubMed ID: 2860374 [No Abstract] [Full Text] [Related]
47. Phototoxicity, Pseudoporphyria, and Photo-onycholysis Due to Voriconazole in a Pediatric Patient With Leukemia and Invasive Aspergillosis. Willis ZI; Boyd AS; Di Pentima MC J Pediatric Infect Dis Soc; 2015 Jun; 4(2):e22-4. PubMed ID: 26407422 [TBL] [Abstract][Full Text] [Related]
48. Porphyrias and photosensitivity: pathophysiology for the clinician. Kakoullis L; Louppides S; Papachristodoulou E; Panos G Postgrad Med; 2018 Nov; 130(8):673-686. PubMed ID: 30296862 [TBL] [Abstract][Full Text] [Related]
49. Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery. Rappersberger K; Hönigsmann H; Ortel B; Tanew A; Konrad K; Wolff K J Invest Dermatol; 1989 Aug; 93(2):201-9. PubMed ID: 2754275 [TBL] [Abstract][Full Text] [Related]
50. [Bullous photodermatitis after treatment with nalidixic acid]. Klaassen CH; Kellerhuis-Verhey van Wijk C Ned Tijdschr Geneeskd; 1976 Feb; 120(6):247-9. PubMed ID: 129711 [No Abstract] [Full Text] [Related]
51. Porphyria cutanea tarda: an intriguing genetic disease and marker. Handler NS; Handler MZ; Stephany MP; Handler GA; Schwartz RA Int J Dermatol; 2017 Jun; 56(6):e106-e117. PubMed ID: 28321838 [TBL] [Abstract][Full Text] [Related]
52. [Electron microscopic findings on liver biopsies in porphyria cutanea tarda]. Stockinger L Wien Z Inn Med; 1966 Nov; 47(11):458-66. PubMed ID: 6005182 [No Abstract] [Full Text] [Related]
53. [Bullous light reaction in treatment with nalidixic acid]. Frödin T; Lindgren S; Vinnerberg A Lakartidningen; 1976 Oct; 73(44):3763. PubMed ID: 135894 [No Abstract] [Full Text] [Related]
57. [Erythropoietic protoporphyria. II. Experimental studies using model systems: photosensitivity and skin changes]. Hönigsmann H Z Hautkr; 1977 May; 52(10):541-64. PubMed ID: 878545 [No Abstract] [Full Text] [Related]